Clinical trial
New Management Strategy of PDA for VLBW Preterm--Comparison of Indomethacin and Ibuprofen
NCT00239512 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Management Strategy of PDA for VLBW Preterm--Comparison of Indomethacin and Ibuprofen
- Lead sponsor
- China Medical University Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 31, 2005
- Completion date
- June 30, 2006
- Enrollment
- 60
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ductus arteriosus, patent, preterm infants